FDA.reportPublic FDA data

NDC 0061-0089 - Posatex

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0061-0089
Package NDCs from labels
0061-0089-01, 0061-0089-02, 0061-0089-03
Manufacturer
Merck Sharp & Dohme Corp.
Effective date
2024-10-29
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Posatex - Merck Sharp & Dohme Corp.Merck Sharp & Dohme Corp.2024-10-29PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0061-0089-01Posatex1 in 1 CARTONSUSPENSION19
0061-0089-01Posatex7.5 g in 1 BOTTLE, PLASTICSUSPENSION7.59
0061-0089-02Posatex1 in 1 CARTONSUSPENSION19
0061-0089-02Posatex15 g in 1 BOTTLE, PLASTICSUSPENSION159
0061-0089-03Posatex30 g in 1 BOTTLE, PLASTICSUSPENSION309
0061-0089-03Posatex1 in 1 CARTONSUSPENSION19

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0061-0089POSATEX (ORBIFLOXACIN, MOMETASONE FUROATE, AND POSACONAZOLE) SUSPENSION [MERCK SHARP & DOHME CORP.]96 package rows20241031_f64232d7-e904-45d5-924d-07850f9c3e3d.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Mometasone FuroateACTIVE INGREDIENT04201GDN4RPOSATEX (ORBIFLOXACIN, MOMETASONE FUROATE, AND POSACONAZOLE) SUSPENSION [SCHERING CORPORATION]1
OrbifloxacinACTIVE INGREDIENT660932TPY6POSATEX (ORBIFLOXACIN, MOMETASONE FUROATE, AND POSACONAZOLE) SUSPENSION [SCHERING CORPORATION]1
posaconazoleACTIVE INGREDIENT6TK1G07BHZPOSATEX (ORBIFLOXACIN, MOMETASONE FUROATE, AND POSACONAZOLE) SUSPENSION [SCHERING CORPORATION]1
MometasoneACTIVE MOIETY8HR4QJ6DW8POSATEX (ORBIFLOXACIN, MOMETASONE FUROATE, AND POSACONAZOLE) SUSPENSION [SCHERING CORPORATION]1
OrbifloxacinACTIVE MOIETY660932TPY6POSATEX (ORBIFLOXACIN, MOMETASONE FUROATE, AND POSACONAZOLE) SUSPENSION [SCHERING CORPORATION]1
posaconazoleACTIVE MOIETY6TK1G07BHZPOSATEX (ORBIFLOXACIN, MOMETASONE FUROATE, AND POSACONAZOLE) SUSPENSION [SCHERING CORPORATION]1
Mineral OilINACTIVE INGREDIENTT5L8T28FGPPOSATEX (ORBIFLOXACIN, MOMETASONE FUROATE, AND POSACONAZOLE) SUSPENSION [SCHERING CORPORATION]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 4 · 70 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
POSACONAZOLEPOSACONAZOLEGolden State Medical Supply, Inc.e883b495-d7e7-6d58-e053-2a95a90a1cd32025-02-24Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
POSACONAZOLEPOSACONAZOLECamber Pharmaceuticals, Inc.c551e121-d5fc-4b35-ba9f-72ce3a314fdc2025-01-31Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
PosaconazolePOSACONAZOLEAvPAKde95df83-a495-1900-e053-2995a90abf242025-01-09Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
POSACONAZOLEPOSACONAZOLELannett Company Inc.94a9b028-a2bc-4f41-884d-2d6c536881fc2024-12-03Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
PosaconazolePOSACONAZOLEi3 Pharmaceuticals, LLCd5300d14-219d-4e1e-bfac-b413c40d6e3a2024-11-29Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
Mometasone FuroateMOMETASONE FUROATEBryant Ranch Prepack43a91066-1d85-4f67-9856-a11c1bb2b22b2024-11-20Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
posaconazolePOSACONAZOLENovadoz Pharmaceuticals LLC0bdf77ae-3639-49c1-b7c7-533f9d0730842024-09-25Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
Mometasone FuroateMOMETASONE FUROATEBryant Ranch Prepack6c7d8133-b71e-4290-bec1-53ff0232998a2024-08-30Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
Childrens NasonexMOMETASONE FUROATEL. Perrigo Companye15d055e-9a25-46b4-8724-3609cf2dc0622024-08-28WarningsExact identifier
unii: 04201GDN4R
Mometasone FuroateMOMETASONE FUROATEBryant Ranch Prepack45c9512b-9463-4684-bfdb-742644d77cc32024-08-14Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
PosaconazolePOSACONAZOLEBryant Ranch Prepackd2daba09-f1c2-4764-a567-1291be4892b92024-07-16Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
Mometasone FuroateMOMETASONE FUROATEProficient Rx LP2bf06b19-4ed7-41a3-b6fc-29713c41965c2024-02-01Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
PosaconazolePOSACONAZOLEFresensius Kabi USA, LLC86be8cdb-c991-4754-b8f4-1ab79ac40bda2023-12-31Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
Mometasone FuroateMOMETASONE FUROATECosette Pharmaceuticals, Inc.f69603aa-a5a6-b8f3-c9ed-2d0abc9f4d922023-11-29Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
Mometasone FuroateMOMETASONE FUROATECosette Pharmaceuticals, Inc.f5b30e5e-b067-e28c-b7c5-aa58f4c57f092023-11-29Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
Mometasone FuroateMOMETASONE FUROATEBryant Ranch Prepackc3053a64-9044-496e-9005-12b4440d46e82023-10-20Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
Mometasone FuroateMOMETASONE FUROATEBryant Ranch Prepackd15edb8b-c8b2-4023-992e-f79cefa2d1e82023-08-16Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
Mometasone FuroateMOMETASONE FUROATEBryant Ranch Prepacka6055a9c-e19c-48ad-a743-c0a7f7366cdd2023-07-18Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
Mometasone FuroateMOMETASONE FUROATEBryant Ranch Prepack5f1f2136-9e10-4d43-bb35-ed285c744fe42023-07-18Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
Mometasone FuroateMOMETASONE FUROATEPadagis Israel Pharmaceuticals Ltd7296b4a2-f180-4887-a8e0-029f81aec5662023-04-21Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.